4BIO Capital Strengthens Advisory Board and Investment
Press Release 4BIO Capital Strengthens Advisory Board and Investment Team Industry veteran and former CEO of Vifor Pharma Abbas Hussain and world...
Source: globenewswire.com
📰 Leszek Lisowski News
Leszek Lisowski News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leszek Lisowski. Real-time updates on events, politics, business and more.
AAV Manufacturing — Overcoming the Challenges of Plasmid DNA, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) November 14, 2022 -- AAV manufacturing and other types of advanced therapy production are experiencing challenges associated with their
Source: prweb.com
DiNAQOR Announces Research Collaboration with Children's Medical Research Institute to Develop Novel, Cardiac Specific Capsids
/PRNewswire/ -- DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has entered into a...
Source: prnewswire.com
Logicbio Therapeutics (LOGC) Gets a Buy Rating from Chardan Capital
Markets In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Logicbio Therapeutics (LOGC – Research Report), with a price target of $20.00. The company’s shares closed last Tuesday at $6.10. According to TipRanks.com, Livshits is a top 100 analyst with an average return of 78.0% and a 71.0% success rate. Livshits covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Crispr Therapeutics AG, and Intellia Therapeutics. Logicbi...
Source: markets.co